Table 2 |
||||||
|
Frequency of use of immunosuppressive agents during the study |
||||||
|
Immunosuppressive drugs |
Placebo (n = 13) |
Belimumab |
||||
|
|
||||||
|
1.0 mg/kg (n = 15) |
4.0 mg/kg (n = 14) |
10 mg/kg (n = 14) |
20 mg/kg (n = 14) |
All active (n = 57) |
||
|
|
||||||
|
Prednisone |
9 (69) |
14 (93) |
9 (54) |
10 (71) |
8 (57) |
41 (72) |
|
Methotrexate |
2 (15) |
1 (7) |
0 |
2 (14) |
3 (21) |
6 (11) |
|
Azathioprine |
5 (38) |
2 (13) |
2 (13) |
2 (14) |
1 (7) |
7 (12) |
|
Mycophenolate |
0 |
1 (7) |
1 (7) |
1 (7) |
5 (36) |
8 (14) |
|
None |
3 (23) |
1 (7) |
5 (36) |
3 (21) |
3 (21) |
12 (21) |
|
|
||||||
|
Furie et al. Arthritis Research & Therapy 2008 10:R109 doi:10.1186/ar2506 |
||||||
